P089: Pembrolizumab in Pediatric and Young Adults Patients With Newly Diagnosed Classical Hodgkin Lymphoma and Slow Early Responders to Frontline Chemotherapy: The Phase 2 KEYNOTE-667 Study

• Luciana Vinti,
• Stephen Daw,
• Constantino Sabado Alvarez,
• Franca Fagioli,
• Auke Beishuizen,
• Gerard Michel,
• Maria Luisa Moleti,
• Michaela Cepelova,
• Anne Thorwarth,
• Charlotte Rigaud,
• Diego Plaza Lopez De Sabando,
• Judith Landman Parker,
• Ying Zhu,
• Pallavi Pillai,
• Akash Nahar,
• Christine Mauz-Koerholz

Affiliations

Luciana Vinti

1 IRCCS Ospedale Pediatrico Bambino Gesu, Rome, Italy

Stephen Daw

2 University College London Hospitals NHS Foundation Trust, London, United Kingdom

Constantino Sabado Alvarez

3 Hospital Universitari Vall d Hebron, Barcelona, Spain

Franca Fagioli

4 Ospedale Infantile Regina Margherita, Turin, Italy

Auke Beishuizen

5 Princess Máxima Centrum, Utrecht, Netherlands

Gerard Michel

6 CHU de Marseille Hopital de la Timone Enfants, Marseille, France

Maria Luisa Moleti

7 Universita degli Studi di Roma La Sapienza, Rome, Italy

Michaela Cepelova

8 Fakultni Nemocnice v Motole, Prague, Czech Republic

Anne Thorwarth

9 Charite-Universitaetsmedizin Berlin Campus Virchow-Klinikum, Berlin, Germany

Charlotte Rigaud

10 Gustave Roussy, Villejuif, France

Diego Plaza Lopez De Sabando

11 Hospital Universitario La Paz, Madrid, Spain

Judith Landman Parker

12 Hopital d’Enfants Armand Trousseau, Paris, France

Ying Zhu

13 Merck & Co., Inc., Rahway, NJ, USA

Pallavi Pillai

13 Merck & Co., Inc., Rahway, NJ, USA

Akash Nahar

13 Merck & Co., Inc., Rahway, NJ, USA

Christine Mauz-Koerholz

14 Justus-Liebig University of Giessen, Giessen, Germany